Limiting the Spread of Multidrug-Resistant Bacteria in Low-to-Middle-Income Countries: One Size Does Not Fit All
- PMID: 36678492
- PMCID: PMC9866331
- DOI: 10.3390/pathogens12010144
Limiting the Spread of Multidrug-Resistant Bacteria in Low-to-Middle-Income Countries: One Size Does Not Fit All
Abstract
The spread of multidrug-resistant organisms (MDRO) is associated with additional costs as well as higher morbidity and mortality rates. Risk factors related to the spread of MDRO can be classified into four categories: bacterial, host-related, organizational, and epidemiological. Faced with the severity of the MDRO predicament and its individual and collective consequences, many scientific societies have developed recommendations to help healthcare teams control the spread of MDROs. These international recommendations include a series of control measures based on surveillance cultures and the application of barrier measures, ranging from patients' being isolated in single rooms, to the reinforcement of hand hygiene and implementation of additional contact precautions, to the cohorting of colonized patients in a dedicated unit with or without a dedicated staff. In addition, most policies include the application of an antimicrobial stewardship program. Applying international policies to control the spread of MDROs presents several challenges, particularly in low-to-middle-income countries (LMICs). Through a review of the literature, this work evaluates the real risks of dissemination linked to MDROs and proposes an alternative policy that caters to the means of LMICs. Indeed, sufficient evidence exists to support the theory that high compliance with hand hygiene and antimicrobial stewardship reduces the risk of MDRO transmission. LMICs would therefore be better off adopting such low-cost policies without necessarily having to implement costly isolation protocols or impose additional contact precautions.
Keywords: antimicrobial resistance and low-to-middle income countries; infection control; multidrug-resistant organisms.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
[Antimicrobial Stewardship and Hygiene: Prevention of Multidrug Resistant Pathogens].Anasthesiol Intensivmed Notfallmed Schmerzther. 2025 Feb;60(2):105-116. doi: 10.1055/a-2298-3011. Epub 2025 Feb 17. Anasthesiol Intensivmed Notfallmed Schmerzther. 2025. PMID: 39961309 Review. German.
-
Controlling the Diffusion of Multidrug-Resistant Organisms in Intensive Care Units.Semin Respir Crit Care Med. 2019 Aug;40(4):558-568. doi: 10.1055/s-0039-1696980. Epub 2019 Oct 4. Semin Respir Crit Care Med. 2019. PMID: 31585481 Review.
-
Prevention in Adults of Transmission of Infection With Multidrug-Resistant Organisms: Rapid Review.2024 Apr. In: Making Healthcare Safer IV: A Continuous Updating of Patient Safety Harms and Practices [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2023 Jul–. 2024 Apr. In: Making Healthcare Safer IV: A Continuous Updating of Patient Safety Harms and Practices [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2023 Jul–. PMID: 38709863 Free Books & Documents. Review.
-
Effectiveness of a Multicomponent Intervention to Reduce Multidrug-Resistant Organisms in Nursing Homes: A Cluster Randomized Clinical Trial.JAMA Netw Open. 2021 Jul 1;4(7):e2116555. doi: 10.1001/jamanetworkopen.2021.16555. JAMA Netw Open. 2021. PMID: 34269807 Free PMC article. Clinical Trial.
-
Status of the Prevention of Multidrug-Resistant Organisms in International Settings: A Survey of the Society for Healthcare Epidemiology of America Research Network.Infect Control Hosp Epidemiol. 2017 Jan;38(1):53-60. doi: 10.1017/ice.2016.242. Epub 2016 Nov 7. Infect Control Hosp Epidemiol. 2017. PMID: 27817759
Cited by
-
Risk factors of multidrug-resistant organisms neonatal sepsis in Surabaya tertiary referral hospital: a single-center study.BMC Pediatr. 2024 Feb 29;24(1):153. doi: 10.1186/s12887-024-04639-9. BMC Pediatr. 2024. PMID: 38424519 Free PMC article.
-
Healthcare challenges in LMICs: addressing antibiotic resistance threats, a call for comprehensive global solutions: an editorial.Int J Surg. 2024 May 1;110(5):3085-3087. doi: 10.1097/JS9.0000000000001165. Int J Surg. 2024. PMID: 38748502 Free PMC article. No abstract available.
-
Reactive Oxygen Species (ROS)-Mediated Antibacterial Oxidative Therapies: Available Methods to Generate ROS and a Novel Option Proposal.Int J Mol Sci. 2024 Jun 29;25(13):7182. doi: 10.3390/ijms25137182. Int J Mol Sci. 2024. PMID: 39000290 Free PMC article. Review.
-
Prevalence and Antibiogram Pattern of Acinetobacter baumannii from 2013 to 2023 in a Tertiary Care Hospital in the Western Region of Saudi Arabia.Antibiotics (Basel). 2025 Mar 7;14(3):274. doi: 10.3390/antibiotics14030274. Antibiotics (Basel). 2025. PMID: 40149085 Free PMC article.
-
Mechanical Ventilator-Associated Pneumonia in the COVID-19 Pandemic Era: A Critical Challenge in the Intensive Care Units.Antibiotics (Basel). 2025 Jan 3;14(1):28. doi: 10.3390/antibiotics14010028. Antibiotics (Basel). 2025. PMID: 39858314 Free PMC article.
References
-
- Global Antimicrobial Resistance and Use Surveillance System (GLASS) Report: 2021. [(accessed on 11 July 2021)]. Available online: https://www.who.int/publications-detail-redirect/9789240027336.
-
- Biggest Threats and Data|Antibiotic/Antimicrobial Resistance|CDC. [(accessed on 22 July 2019)]; Available online: https://www.cdc.gov/drugresistance/biggest_threats.html.
-
- Weiner-Lastinger L.M., Abner S., Edwards J.R., Kallen A.J., Karlsson M., Magill S.S., Pollock D., See I., Soe M.M., Walters M.S., et al. Antimicrobial-resistant pathogens associated with adult healthcare-associated infections: Summary of data reported to the National Healthcare Safety Network, 2015–2017. Infect. Control Hosp. Epidemiol. 2020;41:1–18. doi: 10.1017/ice.2019.296. - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources